| FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer | 09/12 12:35 | zacks.com |
| Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS) | 09/11 07:00 | globenewswire.com |
| Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024 | 09/05 07:00 | globenewswire.com |
| Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment | 08/27 10:18 | seekingalpha.com |
| Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib | 08/06 17:50 | globenewswire.com |
| AGIO Q2 Earnings Lag, Stock Down on Missing Pediatric Study Goal | 08/02 11:46 | zacks.com |
| Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides | 08/01 13:42 | benzinga.com |
| Agios Pharmaceuticals, Inc. (AGIO) Q2 2024 Earnings Call Transcript | 08/01 12:11 | seekingalpha.com |
| Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Lags Revenue Estimates | 08/01 08:45 | zacks.com |
| Agios Reports Business Highlights and Second Quarter 2024 Financial Results | 08/01 06:31 | globenewswire.com |